Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2013
08/22/2013WO2013123513A1 Use of metalloporphyrins and salen complexes for the catalytic oxidation of organic compounds
08/22/2013WO2013122953A1 Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
08/22/2013WO2013122402A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/22/2013WO2013059396A3 Treatment of cancer with tor kinase inhibitors
08/22/2013US20130217951 7-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyrazine derivatives
08/22/2013US20130217878 (aza)indolizine derivative and pharmaceutical use thereof
08/22/2013US20130217720 Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
08/22/2013US20130217698 Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
08/22/2013US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
08/22/2013US20130217693 Compounds and method for treatment of hiv
08/22/2013US20130217685 Compounds for modulating rna binding proteins and uses therefor
08/22/2013US20130217682 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
08/22/2013US20130217680 Inhibitors of the Renal Outer Medullary Potassium Channel
08/22/2013US20130217676 5ht2c receptor modulators
08/22/2013US20130217675 Pyrido [4,3-b] indole and pyrido [3,4-b] indole derivatives and methods of use
08/22/2013US20130217662 Method of treatment using substituted imidazo[1,2b]pyridazine compounds
08/22/2013US20130217661 Quinazoline derivatives
08/22/2013US20130216497 Novel tricyclic compounds
08/21/2013EP2629345A1 Organic electroluminescent element
08/21/2013EP2628741A2 Novel compound of a reverse-turn mimetic and a production method and use therefor
08/21/2013EP2628721A1 Synthesis of 2-(3,4-difluorophenyl)cyclopropanecarboxylic acid
08/21/2013EP2627657A2 Molecular containers and methods of making and using same
08/21/2013EP2627641A1 Reversal of drug-induced neuromuscular block using novel molecular containers
08/21/2013EP2627634A1 A new dimedon derivative and a method for the purification of pna and peptide oligomers
08/21/2013EP2627332A2 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same
08/21/2013EP2543667A9 2-aminopyridine analogs as glucokinase activators
08/21/2013EP2358717B1 Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
08/21/2013CN103261340A Quinone compounds for use in photovoltaics
08/21/2013CN103261202A Fused tricyclic compounds as adenosine receptor antagonist
08/21/2013CN103261201A 2-amino-4-arylthiazole compounds as TRPA1 antagonists
08/21/2013CN103261198A 2-arylimidazo[1,2-]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives
08/21/2013CN103254200A C3N4 nanosheet with molecular-scale thickness as well as preparation method and application thereof
08/21/2013CN103254199A Preparation method of tetra-tert-butylphthalocyaninatogallium fluoride supermolecule nanometer lead
08/21/2013CN103254198A Urotropine production method
08/21/2013CN103254197A Preparation method of anagrelide hydrochloride
08/21/2013CN103254196A Preparation method of pemetrexed diacid
08/21/2013CN103254195A 7-amino-tetrazole[1,5-a] pyrimidine-5-alcohol(compound II) and its synthetic route
08/21/2013CN103254190A Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
08/21/2013CN103254177A Modulators of atp-binding cassette transporters
08/21/2013CN102417511B Acylhydrazone zinc protoporphyrin, and synthesis and application of complex thereof
08/21/2013CN102268004B Chlorophyllin salt compound and preparation method thereof
08/21/2013CN101952296B Pyrrolopyrazine kinase inhibitors
08/21/2013CN101809776B Organic photosensitive optoelectronic devices with nonplanar porphyrins
08/21/2013CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar
08/21/2013CN101415710B Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
08/20/2013US8513436 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
08/20/2013US8513411 Tetrahydro-imidazo[1,5-α] pyrazine derivatives, preparation process and medicinal use thereof
08/20/2013US8513276 Imidazo[1,2-a]pyridine compounds for use in treating cancer
08/20/2013US8513270 Substituted heterocycles as Janus kinase inhibitors
08/20/2013US8513263 Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors
08/20/2013US8513250 Imidazolo-heteroaryl derivatives with antibacterial properties
08/20/2013US8513246 Use of N-heterocyclylmethylbenzamides in therapeutics
08/20/2013US8513238 Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
08/20/2013US8513235 Homocysteine synthase inhibitor
08/20/2013US8513234 HIV integrase inhibitors
08/20/2013US8512755 Compact multifunctional ligand to enhance colloidal stability of nanoparticles
08/20/2013US8512675 N and/or Nα derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH2)3 (CO)3]+ by fac coordination
08/15/2013US20130211083 Process for the preparation of anagrelide and analogues thereof
08/15/2013US20130210877 Pharmaceutical compositions comprising poh derivatives
08/15/2013US20130210839 Fused aminodihydropyrimidine derivative
08/15/2013US20130210838 Pyrazolo[1,5-a]pyrimidines as mark inhibitors
08/15/2013US20130210831 Pyrrolopyrimidine compounds and uses thereof
08/15/2013US20130210829 Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
08/15/2013US20130210828 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY (PHENYLENE) ETHYNYLENES (PPEs)
08/15/2013US20130210827 Novel benzenesulfonamides as calcium channel blockers
08/15/2013US20130210826 Methods for treating pain
08/15/2013US20130210825 Substituted imidazo[1,2-b]pyridazines
08/15/2013US20130210824 Substituted fused imidazoles and pyrazoles and use thereof
08/15/2013US20130210818 Novel Heterocyclic Compounds and Uses Thereof
08/15/2013US20130210816 Fused-imidazoyl compounds useful as antimicrobial agents
08/15/2013US20130210815 Substituted imidazopyrazines
08/15/2013US20130210814 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
08/15/2013US20130210809 Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
08/15/2013US20130210802 Imidazopyridines syk inhibitors
08/15/2013US20130210800 Pyridine-2-derivatives as smoothened receptor modulators
08/15/2013US20130210113 Small molecule dye conjugates
08/15/2013US20130210083 Thermostable enzyme technology for algal bioconversion
08/15/2013US20130209516 Immunomodulatory compositions
08/15/2013US20130209400 Pyrazole derivatives as jak inhibitors
08/14/2013EP2626361A1 Pyrrole antifungal agents
08/14/2013EP2626360A1 Process for the preparation of fused pyrimidineone compounds useful as TRPV3 modulators
08/14/2013EP2626354A1 Viral polymerase inhibitors
08/14/2013EP2625180A2 Porphyrin treatment of neurodegenerative diseases
08/14/2013EP2625179A2 Process for preparing an intermediate of sitagliptin via enzymatic conversion
08/14/2013CN103249731A Hepatitis c virus inhibitors
08/14/2013CN103249723A Pyrazine derivatives as enac blockers
08/14/2013CN103242370A Metal organic gel based on tetrazole compounds
08/14/2013CN103242326A Preparation method of nanometer beta-form titanyl phthalocyanine
08/14/2013CN103242325A Preparation method of nanometer alpha/beta-form metal-free phthalocyanine
08/14/2013CN103242324A Crystal form of 2-((1'- hexyloxy)ethyl)-2- divinyl- pyropheophorbide acid-alpha and preparation method thereof
08/14/2013CN103242323A Nitrogen (sulfur) containing bridge ring compound with insecticidal activity, preparation method and application
08/14/2013CN103242322A Indolocarbazole derivative and application thereof to electroluminescent device
08/14/2013CN103242321A Benzylpiperazine compound and anti-tumor application thereof
08/14/2013CN103242320A Preparation method of Qingdanone
08/14/2013CN103242319A Preparation method of 1, 3, 4, 6-tetranitroglycoluril
08/14/2013CN103242318A Salt of triazole-pyridazine derivative
08/14/2013CN103242317A Salt of cyclopropyl quinoline derivative
08/14/2013CN103242316A Salt of imidazo-triazine derivative
08/14/2013CN103242315A Salt of quinoline benzamide derivative
08/14/2013CN103242116A Novel method for preparing arylamine through reducing aromatic nitro compound
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 573